Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 31 -40 of 784 Show results per page	View Search Criteria \| Help With Results

	Title				Phase				Protocol IDs

	Capecitabine and Paclitaxel (Albumin-Stabilized Nanoparticle Formulation) in Treating Women Undergoing Surgery for Stage II or Stage III Breast Cancer				Phase III, Phase II				WHC-MRI-GU-2006-097 NCT00397761
	Efficacy and Safety of Imatinib and Vinorelbine in Patients With Advanced Breast Cancer				Phase III, Phase II				CSTI571BDE28 NCT00372476
	Standard Versus Continuous Capecitabine in Advanced Breast Cancer				Phase III, Phase II				05/237 NCT00418028
	Intensified IAA With PBPC Support in Breast Tumors With Evidence of a HRD				Phase III, Phase II				N06IAA NCT00448266
	Second-Line Endocrine Treatment Followed by Capecitabine Versus Capecitabine Followed by Endocrine Treatment in Patients With Metastatic ER Positive Breast Cancer				Phase III, Phase II				N07MAN Eudract 2007-007030-20, NCT00684216
	Exemestane, Letrozole, or Anastrozole in Treating Postmenopausal Women With Clinical Stage II and III Estrogen Receptor Positive Breast Cancer				Phase III, Phase II				0120070323 NCT00698971
	Letrozole After Tamoxifen in Treating Women With Breast Cancer				Phase III				CAN-NCIC-MA17 CALGB-49805, E-JMA17, EORTC-10983, IBCSG-BIG97-01, NCCTG-JMA17, SWOG-JMA17, JRF-Vor-Int-10, NCCTG-CAN-MA17, SWOG-CAN-MA17, NCT00003140, JMA17, MA17
	Trastuzumab With or Without Paclitaxel in Treating Women With Metastatic Breast Cancer That Overexpresses HER2				Phase III				SWS-SAKK-22/99 EU-99028, NCT00004935
	Comparison of Complete Axillary Lymph Node Dissection With Axillary Radiation Therapy in Treating Women With Invasive Breast Cancer				Phase III				EORTC-10981 EORTC-10981-AMAROS, NCT00014612
	Combination Chemotherapy After Surgery in Treating Patients With Stage I, Stage II, or Stage III Breast Cancer				Phase III				IBCSG-22-00 EU-20119, NCT00022516, EUDRACT-2005-005666-36


					< Previous 1 2 3 4 5 6 7 Next >

| | | | | | | |

A Service of the National Cancer Institute